Sanofi
OrganizationHeard in 20 episodes across 10 shows since Oct 2025
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. It engages in the research, development, manufacturing, and marketing of therapeutic solutions, with a strong focus on specialty care, vaccines, and general medicines.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Sanofi per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 25 | 0.01‰ | 1 |
| Oct 1 | 0.02‰ | 1 |
| Oct 20 | 0.01‰ | 1 |
| Oct 23 | 0.02‰ | 1 |
| Oct 30 | 0.03‰ | 3 |
| Nov 10 | 0.01‰ | 1 |
| Nov 12 | 0.02‰ | 1 |
| Nov 17 | 0.02‰ | 1 |
| Nov 19 | 0.02‰ | 1 |
| Nov 20 | 0.02‰ | 1 |
Email alert
Email me when Sanofi comes up on a podcast
One email a week at most, with the new episodes that mention Sanofi. Free, no account needed, unsubscribe in one click.
What experts have said about Sanofi
6 statements · 1 positive · 5 negative
Sanofi will need to replace income when the prior drug patent expires in the early 2030s.
“when that patent begins to expire in early 2030s, they then need to replace that income.”
Open the episode · AG Barr Drops, LandSec Falls, Sanofi GainsListen at 4:19
Sanofi shares rose about 3.7% in Paris after the partnership news.
“shares rising on the back of that, they're up about 3.7% in Paris.”
Open the episode · AG Barr Drops, LandSec Falls, Sanofi GainsListen at 4:27
Sanofi needs to expand its drug pipeline further.
“intensifies that need for that pipeline to be built out more”
Open the episode · SAP Beats, Sanofi Dips, Arcadis GainsListen at 2:50
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
20 episodes featuring Sanofi, newest first
- Nov 20, 2026
Biotech weighs AI disruption against a stronger 2027 deal cycleBiotech HangoutNov 20, 2026 - Nov 19, 2026
Anthropic’s debut tests AI valuations as markets retreatCNBC's "Fast Money"Nov 19, 2026 - Nov 17, 2026
AI agents automate attacks as Linux flaw and weak passwords persistCybersecurity HeadlinesNov 17, 2026 - Nov 12, 2026
Biotech’s uncertainty creates disciplined investment opportunitiesThe Acquirers PodcastNov 12, 2026 - Nov 10, 2026
Midterms Put FDA Leadership and Drug Pricing in PlayBioCentury This WeekNov 10, 2026 - Oct 30, 2026
Biotech weighs AI promise against biology’s stubborn bottlenecksBiotech HangoutOct 30, 2026